Faculty Information - YAGISAWA Takafumi

（Last updated : 2026-10-29 14:55:39）

YAGISAWA Takafumi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Original article	Clinical significance of persistent C4d deposition on sequential protocol biopsies in ABO-incompatible kidney transplantation. 2026/10/06
2.	Other	Effectiveness and safety of enfortumab vedotin plus pembrolizumab for patients aged 80 years and older with metastatic urothelial carcinoma: A multicenter retrospective study. 2026/08
3.	Original article	Feasibility and strategic endoscopic management of de novo kidney allograft stones: a retrospective study. 2026/04
4.	Other	Editorial comment on "Outcomes of mini-endoscopic combined intrarenal surgery in the geriatric population: A matched pair analysis" 2026/03
5.	Case report	Safety management of kidneytransplantation in patients with Behçet’s disease: A case report with literature review 2026/02/10
6.	Original article	Risk assessment of cytomegalovirus reactivation after kidney transplantation under a universal preemptive strategy in the era of intravenous immunoglobulin-based desensitization therapy. 2026/02
7.	Other	The coeffi cient of variation of tacrolimus QD at 1 year posttransplant is associated with mid-long term kidney graft function. 2025/08
8.	Original article	Outcomes of kidney transplantation in recipients with SARS-cov-2 infection: a 282-case single-center experience in Japan. 2025/02
9.	Original article	Editorial comment on "Herpes zoster development in living kidney transplant recipients receiving low-dose rituximab" 2025/01
10.	Case report	Tips for percutaneous nephrolithotomy for transplant kidney stone. 2024/10/13
11.	Original article	Comparative analysis of real-world efficacy and safety of hypoxia-inducible factor prolyl-hydroxylase inhibitors in kidney transplant recipients versus nontransplant individuals: A single-center study. 2024/07
12.	Original article	Editorial comment on "Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan" 2024/07
13.	Original article	Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis. 2024/04/14
14.	Original article	The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks. 2024/04
15.	Original article	Higher donor age and severe microvascular inflammation are risk factors for chronic rejection after treatment of active antibody-mediated rejection. 2024/02
16.	Original article	En bloc kidney transplantation from pediatric donors to teenage recipients: Two case reports. 2023/12/27
17.	Original article	Kidney transplantation after multiple urinary tract conversion with an ileal conduit: A case report. 2023/05/14
18.	Original article	Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. 2023/05/04
19.	Original article	A Comparative Study on the Variation in Seropositivity Rates After 2-Dose COVID-19 Vaccination Before or After Transplant: A Single-Center Analysis. 2022/12
20.	Original article	Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. 2022/06
21.	Original article	Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection. 2021/07/08
22.	Original article	Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility. 2020/06
23.	Original article	In the absence of natural killer cell activation donor-specific antibody ediates chronic, but not acute, kidney allograft rejection. 2019/02
24.	Original article	Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy. 2017/02
25.	Original article	Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer. 2016/03
26.	Original article	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015/07
27.	Case report	Combination of molecular targeted therapy and surgery for a patient with metastatic renal cell carcinoma with a poor prognosis. 2015/07
28.	Other	The phenotype of repopulating B cell after rituximab therapy in kidney transplant patients. 2014/11
29.	Original article	A case of focal segmental glomerulosclerosis diagnosed as the original underlying disease after cadaveric renal transplantation 2012/09
Display 5 items
Display all(29)

■ Academic conference presentation

1.	A Case of amyloidosis diagnosed by allograft kidney biopsy after living-donor kidney transplantation. （Speech，General） 2026/07/25
2.	Clinical and pathological analyses of living donor kidney transplantation cases with positive crossmatch. （Speech，General） 2026/07/25
3.	Spatial transcriptome analysis identified HLA-F as a novel biomarker of ABMR. （Speech，General） 2026/07/25
4.	Clinical outcomes of surgically treated urachal remnants: A study at our institution （Speech，General） 2026/04/25
5.	Prognostic evaluation of Tacrolimus serum concentration fluctuation rate and transplanted kidney function in kidney transplant patients. （Speech，General） 2026/04/23
6.	ABO incompatible kidney transplantation. （Speech，Panelist at Symposium/Workshop (Other)） 2025/11/22
7.	The coefficient of variation of tacrolimus QD at 1 year posttransplant is associated with mid-long term kidney graft function. （Poster notice，General） 2025/08/04
8.	Clinicopathological evaluation of living-related kidney transplantation from older adult donors: A focus on zero-time biopsy findings. （Poster notice，General） 2024/06/04
9.	Introducing robotic approach to radical nephrectomy: single-institution comparison with laparoscopic approach. （Poster notice，General） 2024/04/26
10.	Assessing long-term complications of kidney transplantation without intraoperative ureteral dj stent: A single-center experience. （Poster notice，General） 2023/06/06
11.	Elderly living kidney transplant donors and their renal prognosis. （Poster notice，General） 2023/06/06
12.	The outcome of kidney transplantation after cancer treatment in the patient with high estimated cure rate. （Poster notice，General） 2023/06/06
13.	Donor-derived cell-free DNA analysis is capable of detecting antibody-mediated rejection in one-year biopsy of living kidney transplantation. （Poster notice，General） 2023/06/05
14.	Effects and side effects of desensitization therapy in flow cytometry crossmatch-negative, Low-dose donor-specific antibody-positive renal transplant recipients. （Poster notice，General） 2023/06/04
15.	Impact of current desensitization protocols and surgical outcomes in ABO-incompatible kidney transplant recipients: A Japanese single-center experience. （Poster notice，General） 2023/06/04
16.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. （Poster notice，General） 2023/06/03
17.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. （Poster notice，General） 2023/06/03
18.	Postoperative management of renal transplantation: what you need to know. （Speech，Panelist at Symposium/Workshop (Other)） 2023/04/21
19.	Donor-derived cell-free DNA analysis is capable of detecting antibody-mediated rejection in one-year biopsy of kidney allograft. （Speech，General） 2023/04/20
20.	Cost effectiveness of kidney transplantation in high-immunological risk patients in a Japan cohort. （Speech，General） 2022/11/26
21.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. （Speech，General） 2022/11/26
22.	Outcomes of ABO-compatible living kidney transplantation recipients with low immunological risk. （Speech，General） 2022/11/26
23.	Outcomes of treatments for acute antibody-mediated rejection after kidney transplantation. （Speech，General） 2022/11/26
24.	A case of kidney transplantation after multiple urinary tract conversion with an ileal conduit. （Speech，General） 2022/11/25
25.	En bloc kidney transplant from pediatric donors to teenage recipients: A single-center experience. （Speech，General） 2022/11/25
26.	Evaluation of cases of cytomegalovirus infection after renal transplantation at our department. （Speech，General） 2022/11/25
27.	Preconception care and pregnancy complications after kidney transplantation: A single-center study. （Speech，General） 2022/11/25
28.	Recurrence of cancer in 188 kidney transplant recipients. （Speech，General） 2022/11/25
29.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. （Poster notice，General） 2022/10/24
30.	Urology beyond Europe - Joint Session of the European Association of Urology (EAU) and the Japanese Urological Association (JUA) （Speech，Panelist at Symposium/Workshop (Other)） 2022/07/01
31.	Antibody response to sars-CoV-2 vaccine among kidney transplant recipients: A retrospective cohort study. （Speech，General） 2022/06/06
32.	Two times or more double-filtration plasmapheresis increases the risk of bleeding during kidney transplantation. （Poster notice，General） 2022/06/05
33.	Impact of rituximab induction therapy on donor-specific anti-HLA antibodies in abo-compatible kidney transplant recipients. （Poster notice，General） 2021/06/04
34.	The evaluation of living-related kidney transplantation donors in autosomal-dominant polycystic kidney disease. （Poster notice，General） 2021/06/04
35.	Donor-specfic antibody mediates chronic, but not acute, kidney allograft rejection in the absence of natural killer cells. （Speech，General） 2018/06/05
36.	The degree of NK cell activation determines the ability of donor-specific antibodies to mediate acute vs. chronic rejection of kidney allografts. （Speech，General） 2017/05/01
37.	The degree of NK cell activation determines the ability of donor-specific antibodies to mediate acute vs. chronic rejection of kidney allografts. （Speech，General） 2017/04/07
38.	Allograft TLR4 receptor signaling induces specific early inflammatory events in promotes allografts subjected to prolonged cold ischemic storage. （Poster notice，General） 2016/06/13
39.	The relationship between the timing of maximum tumor shrinkage during 1st-line targeted therapy and overall survival of patients with metastatic renal cell carcinoma. （Poster notice，General） 2015/05/18
40.	Excellent outcomes of prophylactic rituximab administration with plasmapheresis in kidney transplant recipients with focal segmental glomerulosclerosis. （Poster notice，General） 2015/05/02
41.	ERECTILE DYSFUNCTION RISK FACTORS IN PATIENTS WITH SEVERE OBSTRUCTIVE SLEEP APNEA SYNDROME AND IDENTIFYING CPAP RESPONSE PREDICTORS （Poster notice，General） 2014/09/22
42.	Histological findings at zero-time biopsy have an important role in the diagnosis of chronic tacrolimus nephrotoxicity （Poster notice，General） 2013/11/08
43.	RESUL OF TRANSURETHRAL URETEROLITHOTRIPSY(TUL) AND CLINICAL CHARACTERISTICS OF ACUTE PYELONEPHRITIS FOLLWING TUL （Speech，General） 2013/10/25
44.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution （Poster notice，General） 2013/09/04
45.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity （Speech，General） 2013/09/04
46.	Risk Factor for Erectile Dysfunction in Patients with SAS and Predictor Identifying Responders to CPAP （Poster notice，General） 2013/06/27
47.	Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity （Poster notice，General） 2013/05/19
48.	Usefulness of temporary inferior vena cava filter in preventing intraoperative pulmonary embolism for patients with renal cell carcinoma extending into inferior vena cava thrombus （Poster notice，General） 2013/05/07
49.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy （Speech，General） 2012/04/23
Display 5 items
Display all(49)

■ Education

1.	2015/06～2018/03	Lerner Research Institute, Cleveland Clinic, Studying abroad
2.	2011/04～2014/12	〔Doctoral course〕〔Doctorial Course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,
3.	2003/04～2009/03	Faculty of Medicine, Saitama Medical University, Graduated